Pregabalin for the treatment of neuropathic pain: a narrative review for primary care providers
- PMID: 28426255
- DOI: 10.1080/03007995.2017.1322051
Pregabalin for the treatment of neuropathic pain: a narrative review for primary care providers
Abstract
Background: Neuropathic pain (NeP) is a distinct type of pain caused by damage to the nervous system itself. This often severe and chronic type of pain requires specific treatments that target the underlying pain pathophysiology.
Aim: The purpose of the current narrative review is to provide an overview of pregabalin (Lyrica 1 ) for the treatment of NeP including its effects on pain, pain-related sleep interference, and other health-related outcomes, timing of therapeutic effect, safety and tolerability, and dosing. The information provided here will help primary care providers develop more effective NeP treatment strategies.
Keywords: Pregabalin; neuropathic pain; primary care; review.
Similar articles
-
Effect of Concomitant Pain Medications on Response to Pregabalin in Patients with Postherpetic Neuralgia or Spinal Cord Injury-Related Neuropathic Pain.Pain Physician. 2017 Jan-Feb;20(1):E53-E63. Pain Physician. 2017. PMID: 28072797 Clinical Trial.
-
Pregabalin for neuropathic pain in primary care settings: recommendations for dosing and titration.Postgrad Med. 2021 Jan;133(1):1-9. doi: 10.1080/00325481.2020.1857992. Postgrad Med. 2021. PMID: 33423590
-
Examining the Time to Therapeutic Effect of Pregabalin in Spinal Cord Injury Patients With Neuropathic Pain.Clin Ther. 2015 May 1;37(5):1081-90. doi: 10.1016/j.clinthera.2015.02.028. Epub 2015 Apr 4. Clin Ther. 2015. PMID: 25850879
-
Clinical and resource utilization patterns in patients with refractory neuropathic pain prescribed pregabalin for the first time in routine medical practice in primary care settings in Spain.Pain Med. 2013 Dec;14(12):1954-63. doi: 10.1111/pme.12276. Epub 2013 Oct 30. Pain Med. 2013. PMID: 24330229
-
Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders.Clin Ther. 2007 Jan;29(1):26-48. doi: 10.1016/j.clinthera.2007.01.013. Clin Ther. 2007. PMID: 17379045 Review.
Cited by
-
Comparison of the use of opioids only and pregabalin add-on for the treatment of neuropathic pain in cervical myelopathy patients: a pilot trial.Sci Rep. 2020 May 15;10(1):8120. doi: 10.1038/s41598-020-65108-8. Sci Rep. 2020. PMID: 32415211 Free PMC article. Clinical Trial.
-
Baicalin relieves neuropathic pain by regulating α2-adrenoceptor levels in rats following spinal nerve injury.Exp Ther Med. 2020 Sep;20(3):2684-2690. doi: 10.3892/etm.2020.9019. Epub 2020 Jul 17. Exp Ther Med. 2020. PMID: 32765762 Free PMC article.
-
Pregabalin in the Management of Painful Diabetic Neuropathy: A Narrative Review.Diabetes Ther. 2019 Feb;10(1):35-56. doi: 10.1007/s13300-018-0550-x. Epub 2018 Dec 18. Diabetes Ther. 2019. PMID: 30565054 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources